UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 5, 2012

 

 

Graymark Healthcare, Inc.

(Exact name of registrant as specified in charter)

 

 

 

Oklahoma   001-34171   20-0180812

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

204 N. Robinson Avenue, Suite 400

Oklahoma City, Oklahoma 73102

(Address of Principal Executive Offices) (Zip Code)

(405) 601-5300

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders

The Company’s 2012 Special Meeting of Shareholders was held on November 5, 2012. The matters voted upon and the number of votes cast for, against or withheld as well as the number of absentions and broker non-votes, as to each such matter are set forth below.

 

1. Amendment of Graymark Healthcare, Inc. Restated Certificate of Incorporation to Effect a Reverse Stock Split. A proposal to approve the amendment of the Company’s Restated Certificate of Incorporation to effect a reverse stock split was approved based on the following votes:

 

Votes For

   Votes Against    Abstentions    Broker Non-Votes

7,599,057

   1,049,440    150    —  


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    By:   GRAYMARK HEALTHCARE, INC.

Date: November 5, 2012

    By:  

/s/    Stanton Nelson

      Stanton Nelson
      Chief Executive Officer